Remove Arrhythmia Remove Atrial Fibrillation Remove Tachycardia
article thumbnail

PO-03-100 EARLY ONSET ATRIAL FIBRILLATION AND CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA WITH TRIADIN MUTATION IN A TACTICAL ATHLETE

HeartRhythm

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare disorder presenting as exercise-induced ventricular arrhythmias, rarely associated with mutations in triadin (TRDN).

article thumbnail

Incidental Arrhythmias During Atrial Fibrillation Screening With Repeat 7?Day Holter ECGs in a Hospital?Based Patient Population

Journal of the American Heart Association

BackgroundScreening for atrial fibrillation (AF) may reveal incidental arrhythmias of relevance. We furthermore report treatment decisions because of incidental arrhythmias. We furthermore report treatment decisions because of incidental arrhythmias. We found incidental arrhythmias in 94 patients (11.8%).

article thumbnail

Volta Medical Enters into Joint Development Agreement with GE HealthCare to Support Electrophysiologists Treating Atrial Fibrillation

DAIC

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Our mission to combat complex heart rhythm diseases relies on optimizing interoperability.

article thumbnail

Atrial dilatation in Atrial fibrillation : A query with multiple twists!

Dr. S. Venkatesan MD

When atrial fibrillation (AF) begins, it can start with a single focus, degenerating to multiple wavelets, and it spreads throughout the entire surface area of both atria. A fibrillatory wave that occurs at a rate of more than 600 beats per minute can cause fatigue in the long run, leading to atrial dilation.

article thumbnail

PO-05-111 CLINICAL OUTCOMES OF CATHETER ABLATION FOR ATRIAL FIBRILLATION, ATRIAL FLUTTER, AND ATRIAL TACHYCARDIA IN WILD-TYPE TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: A PROPOSED TREATMENT STRATEGY FOR CATHETER ABLATION IN EACH ARRHYTHMIA

HeartRhythm

Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) is often accompanied by atrial fibrillation (AF), atrial flutter (AFL), and atrial tachycardia (AT), which are difficult to control because beta-blockers and antiarrhythmic drugs can worsen heart failure (HF).

article thumbnail

PO-02-168 EVALUATION OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ALGORITHM ACCURACY IN DIFFERENTIATING SUPRAVENTRICULAR TACHYCARDIA FROM ATRIAL FIBRILLATION.

HeartRhythm

The rate of ICD implantation has risen due to the increasing population age and the growing prevalence of cardiac arrhythmias. Patients with ICDs who experience atrial fibrillation (AF) have a higher risk of stroke, heart failure, and mortality.

article thumbnail

Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

DAIC

Unlike paroxysmal AF, which describes symptoms that last for seven days or fewer, persistent AF is a sustained arrhythmia that lasts for more than a week 1. Early treatment of persistent AF can reduce the risk of blood clots, stroke, and heart failure, and may prevent the disease from becoming permanent. Circulation.